Bruker Corporation today announced its annual new product booth tour for institutional investors and financial analysts at Pittcon 2008 in New Orleans. The investor tour will start promptly on Tuesday, March 4th at 10 a.m. Central Time at the Company's booth #4041, and will last approximately 45 minutes. To participate, please RSVP to michael.willett@bruker.com. The investor tour will include opening remarks by President and CEO Frank Laukien.
BILLERICA, Mass. (Business Wire EON) February 27, 2008 --
Bruker Corporation today announced its annual new product booth tour for
institutional investors and financial analysts at Pittcon 2008 in New
Orleans. The investor tour will start promptly on Tuesday, March 4th
at 10 a.m. Central Time at the Company’s booth
#4041, and will last approximately 45 minutes. To participate, please
RSVP to michael.willett@bruker.com.
The investor tour will include opening remarks by President and CEO
Frank Laukien.
On Tuesday, March 4th, Bruker will also host its
annual Pittcon press luncheon for journalists and editors of scientific
and trade journals, starting at 12:00 noon in the New Orleans Marriott
Hotel at the Convention Center. This press conference will include
approximately 30 minutes of new product presentations, followed by a Q&A
session (not intended for the financial community). For complete details
and to RSVP, please visit www.bruker.com/pittcon-press
or contact haydar.kustu@bruker.com
.
Bruker expects to introduce numerous innovative high-performance systems
and solutions for life science and materials research, for molecular
diagnostics and imaging research, for homeland security, as well as for
applied and industrial analysis at Pittcon.
Selected new products and solutions that will be introduced and shown by
Bruker at Pittcon 2008 include:
-
the unique Complete Molecular Confidence™
solution for small molecule analysis, combining unambiguous on-the-fly
molecular formula determination followed by molecular structure
verification or determination,
-
a novel, very powerful small molecule and drug imaging MALDI-FTMS
solution for drug development, biological research and clinical
research,
-
new compact and portable FT-IR systems for the identification of
suspicious powders and of distant chemical clouds for homeland
security and environmental/industrial monitoring,
-
new combustion analysis and spark-OES systems for metals analysis, and
-
new analytical service program offering measurements on a wide range
of Bruker techniques;
Several additional new Bruker high-performance products will be
announced at Pittcon.
Pittcon 2008, the 59th Pittsburgh Conference and Exposition on
Analytical Chemistry and Applied Spectroscopy, is being held Sunday,
March 2nd through Thursday, March 6th in the New
Orleans Convention Center. For further information, please visit www.pittcon.org
ABOUT BRUKER (NASDAQ: BRKR)
As of February 26, 2008, the renamed Bruker Corporation has become the
parent company of the entire Bruker group of companies. After the
closing of the acquisition of the Bruker BioSpin Group, Bruker
Corporation now operates in two segments, the life science and
analytical (LSA) systems segment, and the international advanced
superconductor (IAS) segment. For more information, please visit www.bruker-biosciences.com.
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1Qcm9mLUhvcnItU2luZy1Ib3JyLVplcm8=
|